Remission of Type 2 Diabetes with High-Fiber, Low-Fat, and Calorie Restricted Plant-Based Diet Study
Gunadhar Panigrahi, MD, FACC, DipABLM
Article Type: Clinical Research | First Published: March 11, 2023
Type 2 Diabetes (T2D) is a chronic progressive disease, and its prevalence is on the rise around the world. Despite advances in pharmacotherapy, mitigating the burden of the disease on individuals, societies and the healthcare system remains a challenge. Remission has emerged as a therapeutic target in T2D with wide range of interventions. A plant-based diet seems to be promising to achieve this goal. The present study is conducted to establish the feasibility of achieving remission of type 2 di...
High Rate of Mortality in Children and Youth with HIV Infection Compared to those with Diabetes in Tanzania
Edna S Majaliwa MD, MMED, FESPE, Joel Ndayongeje BSC, MSC MPh, Kaushik Ramaiya MBBS, MMED, Blandina T Mmbaga MD, MMED, PhD and Sayoki G Mfinanga MD, PhD
Article Type: Original Article | First Published: March 11, 2023
Pediatric and youth diabetes mellitus (DM) and pediatric and youth human immunodeficiency virus (HIV) infection are among the chronic diseases with significant public health implications and high mortality. The availability of mortality statistics in type 1 diabetes and HIV/AIDS is critical for addressing the two conditions in one setting. To compare the mortality of children and youth living with Diabetes (CYLDM) versus children and youth living with HIV (CYLHIV)....
Utilization of Continuous Glucose Monitors in a Group Medical Visit Setting
Laura A. Buchanan, MD, Matthew W. Calkins, MD, Charlotte T. Boyd, MA, Erin M. Saner, MD, Carmen G. Strickland, MD, John G, Spangler, MD and Julienne K. Kirk, PharmD*
Article Type: Brief Report | First Published: December 29, 2022
The aim of this study is to assess the utilization of CGMs in a GMV setting to improve patient activation and engagement, quality of life, and metabolic outcomes including glycemic control through modified lifestyle behaviors in patients with Type 2 diabetes. Group medical visits (GMV) are an evidence- based care model shown to improve outcomes in diabetes. Monitoring tools that readily demonstrate cause-and-effect relationships between recommended lifestyle interventions and optimal glycemic c...
Diabetes and Driving - Significant Deficits in Knowledge and Practice
IN Khan, F Capatana, LD Premawardhana and MA Adlan
Article Type: Research Article | First Published: December 22, 2022
Motor vehicle drivers who are diabetic and health care professionals who care for them, lack awareness of regulations pertaining to safe driving. We aim to assess their knowledge, practice, and adherence to recommendations in this study of diabetics who drive while taking hypoglycaemic agents....
Intelligent Prophylaxis of Diabetic Foot Ulcer
Arthur Grünerbel and Lorenz Grünerbel
Article Type: Clinical Study | First Published: September 30, 2022
A high skin surface pressure at the feet over a longer period of time can cause foot ulcers. It can occur due to insufficient relief of tissue and a lack of alarm signals from the nervous system, especially for patients with Diabetic Polyneuropathia. A healthy person would move and relieve the foot after a while. A medical wearable can warn a patient without natural alarm signals....
What Impact Does Glycemic Control Have on the Final Outcome of Diabetic Patients with Severe COVID-19?
Fadila Salmane, Faïza Charif, Zaynab Mahdi, Rayhana Rahouti, Hafça Lahbib, Aouatif Boucht, Meryem Smouni, Ouassima Bernichi, Mohamed Hannana, Wiam Ftouh, Hicham Sbai, Ismail Labib, Youssef Moutiaa, Adil Najdi and Mariam Benkacem
Article Type: Original Research | First Published: September 30, 2022
Diabetes represents one of the most frequently reported comorbidities in patients with COVID-19 disease; and is a risk factor for disease progression, and death. Assessing the impact of glycemic control on the progression of Covid-19 disease....
Changing the Face of Diabetes
Stanley S Schwartz, MD, FACP, FACE
Article Type: Short Commentary | First Published: May 28, 2022
To be clear, this is not a criticism of current doctrine or those that came before us. In fact, this is a call to recognize that time, knowledge, and understanding marches forward and we should not be too slow to appreciate this fact....
Skin Barrier Changes in T1DM and T2DM
Priyanka Prabhakar Poonja, MBBS, MSc
Article Type: Review Article | First Published: April 15, 2022
Cutaneous manifestations of diabetes mellitus (DM) are a group of skin disorders that characteristically arise from prolonged chronic hyperglycemia and impaired insulin signaling or insulin resistance. There are several skin diabetic pathologies associated with the two main types of diabetestype 1 (T1DM) and type 2 diabetes (T2DM), which tend to negatively impact the patients quality of life. The literature reveals variations in the skin barrier changes between the two DM types, and this may pro...